Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 5/20 | 0.54 |
| ▸ | EHMT2 | Q96KQ7 | 4/20 | 0.54 |
| ▸ | RAD52 | P43351 | 4/20 | 0.51 |
| ▸ | POLB | P06746 | 3/20 | 0.51 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.51 |
| ▸ | FLT3 | P36888 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.46 |
| ▸ | RCOR1 | Q9UKL0 | 4/20 | 0.46 |
| ▸ | TOP2A | P11388 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.45 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.45 |
| ▸ | TERT | O14746 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14585305 | 0.93 | POLB (0.61) | KDM1AEHMT2RAD52POLBRXFP1 | |
| SCHEMBL14585340 | 0.92 | KDM1A (0.52) | KDM1AEHMT2RAD52POLBRXFP1 | |
| SCHEMBL4631081 | 0.91 | KDM1A (0.63) | KDM1AEHMT2RAD52POLBRXFP1 | |
| SCHEMBL14585313 | 0.89 | POLB (0.61) | KDM1AEHMT2RAD52POLBRXFP1 | |
| SCHEMBL14585338 | 0.89 | ALDH1A1 (0.57) | KDM1AEHMT2RAD52POLBRXFP1 | |
| SCHEMBL14585300 | 0.89 | KDM1A (0.56) | KDM1AEHMT2RAD52POLBRXFP1 | |
| SCHEMBL14585343 | 0.89 | KDM1A (0.56) | KDM1AEHMT2RAD52POLBRXFP1 | |
| SCHEMBL14628155 | 0.89 | KDM1A (0.58) | KDM1AEHMT2RAD52POLBRXFP1 | |
| SCHEMBL14585316 | 0.88 | KDM1A (0.53) | KDM1AEHMT2RAD52POLBRXFP1 | |
| SCHEMBL14585303 | 0.87 | RAD52 (0.54) | KDM1AEHMT2RAD52POLBRXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070032502-A1 | Quinazoline derivatives useful in cancer treatment | SCHERING CORPORATION | 2007-02-08 | — | — | US | disclosed |
| US-20070032502-A1 | Quinazoline derivatives useful in cancer treatment | SCHERING CORPORATION | 2007-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070032502-A1 | Quinazoline derivatives useful in cancer treatment | TP53, ACIN1, TP53BP1 | KDM1A 1966/4885EHMT2 3519/4885RAD52 920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.